论文部分内容阅读
进一步了解肿瘤标志物与基因检测在判断结直肠肿瘤患者预后中的价值，我们选用与大肠肿瘤关系甚密的ｐ５３基因，结合术前大肠相关抗原ＣＥＡ，ＣＡ１９－９的检测，对大肠癌患者的预后作一初步评价１材料和方法１．１材料１９９６－０３／１９９７－０６，对５４例结直肠癌患
To further understand the value of tumor markers and gene detection in judging the prognosis of patients with colorectal cancer, we selected the p53 gene closely related to colorectal tumors, combined with preoperative detection of large intestine-associated antigen CEA, CA19-9, for patients with colorectal cancer. A preliminary evaluation of the prognosis 1 Materials and methods 1.1 Materials 1996-03/1997-06, 54 cases of colorectal cancer